Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Tafenoquine Succinate Tafenoquine Succinate 178429-62-4 C10H14N2O2
Evocalcet Evocalcet 870964-67-3 C24H26N2O2
Indacaterol Indacaterol 312753-06-3 C24H28N2O3
Relebactam Relebactam 1174018-99-5 C12H20N4O6S
Lurbinectedin Lurbinectedin 497871-47-3 C41H44N4O10S
Gilteritinib Gilteritinib 1254053-43-4 C29H44N8O3
Binodenoson Binodenoson 144348-08-3 C17H25N7O4
Ulinastatin Ulinastatin 80449-31-6 C13H16O3
 ALC-0315 ALC-0315 2036272-55-4 C48H95NO5
2-benzyl-1H-benzimidazole monohydrochloride 2-benzyl-1H-benzimidazole monohydrochloride 1212-48-2 C14H13ClN2
Belzutifan Belzutifan 1672668-24-4 C17H12F3NO4S
Mobocertinib succinate Mobocertinib succinate 2389149-74-8 C36H45N7O8
Metonitazene Metonitazene 14680-51-4 C21H26N4O3
Abemaciclib Abemaciclib 1231929-97-7 C27H32F2N8
LasMiditan LasMiditan 439239-90-4 C19H18F3N3O2
Eptifibatide Acetate Eptifibatide Acetate 148031-34-9 C35H49N11O9S2
3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) 3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) 1823274-68-5 C17H18ClNO3
yk11 yk11 1370003-76-1 C25H34O6
(±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride (±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride 60398-91-6 C16H24ClNO2
GUVACINE HYDROCHLORIDE GUVACINE HYDROCHLORIDE 6027-91-4 C6H10ClNO2
SB218078 SB218078 135897-06-2 C24H15N3O3
Azacosterol dihydrochloride Azacosterol dihydrochloride 1249-84-9 C25H45ClN2O
Theodrenaline Theodrenaline 13460-98-5 C17H21N5O5
Furamidine dihydrochloride Furamidine dihydrochloride 55368-40-6 C18H16N4O
Dexrazoxane hydrochloride Dexrazoxane hydrochloride 149003-01-0 C11H16N4O4.ClH
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid 594839-88-0 C14H7Cl2NO3
Regorafenib (Hydrochloride) Regorafenib (Hydrochloride) 835621-07-3 C21H16Cl2F4N4O3
Cariprazine hydrochloride Cariprazine hydrochloride 1083076-69-0 C21H33Cl3N4O
Elobixibat Elobixibat 439087-18-0 C36H45N3O7S2
DASA-58 DASA-58 1203494-49-8 C19H23N3O6S2
LGD-3303 LGD-3303 917891-35-1 C16H14ClF3N2O
5-Aminouridine 5-Aminouridine 2149-76-0 C9H13N3O6
CINACALCET CINACALCET 226256-56-0 C22H22F3N
Ensitrelvir Ensitrelvir 2647530-73-0 C22H17ClF3N9O2
MonoMethylauristatin F MonoMethylauristatin F 745017-94-1 C39H65N5O8
Dapagliflozin propanediol monohydrate Dapagliflozin propanediol monohydrate 960404-48-2 C24H33ClO8
Umbralisib Umbralisib 1532533-67-7 C31H24F3N5O3
ITI-722 ITI-722 313368-91-1 C24H28FN3O
Bremelanotide acetate Bremelanotide acetate 1607799-13-2 C52H72N14O12
Cibinetide Cibinetide 1208243-50-8 C51H84N16O21
Bictegravir Bictegravir 1611493-60-7 C21H18F3N3O5
SN-001 SN-001 727699-84-5 C26H21FN2O4S
THAL-SNS-032 THAL-SNS-032 2139287-33-3 C40H52N8O10S2
Ensitrelvir Ensitrelvir 1471484-62-4 C30H33N5O5S
ZLc002 ZLc002 308277-46-5 C10H17NO5
INDOMETHACIN SODIUM INDOMETHACIN SODIUM 7681-54-1 C19H15ClNNaO4
BI-2865 BI-2865 2937327-93-8 C23H27N7O2S
atpenin A5 atpenin A5 119509-24-9 C15H21Cl2NO5
Eltrombopag Eltrombopag 496775-61-2 C25H22N4O4
MIRODENAFIL MIRODENAFIL 862189-95-5 C26H37N5O5S
Trolox Trolox 53188-07-1 C14H18O4
AT-56 AT-56 162640-98-4 C25H27N5
Avatrombopag Avatrombopag 570406-98-3 C29H34Cl2N6O3S2
Lemborexant Lemborexant 1369764-02-2 C22H20F2N4O2
Pamiparib Pamiparib 1446261-44-4 C16H15FN4O
Rupatadine Rupatadine 158876-82-5 C26H26ClN3
SD208 (TGF-Β/SMAD inhibitor) SD208 (TGF-Β/SMAD inhibitor)
MRGPRX1 agonist 1 MRGPRX1 agonist 1 2377379-39-8 C23H21N3O4S
BI-2493 BI-2493 2937344-16-4 C24H27N7OS
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione 865854-05-3 C19H14N2O2S
VcMMAE VcMMAE 646502-53-6 C68H105N11O15
PLX3397 (Pexidartinib) PLX3397 (Pexidartinib) 1029044-16-3 C20H15ClF3N5
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid 1335316-40-9 C13H22N2O5
DM4 DM4 796073-69-3 C38H54ClN3O10S
Secukinumab Secukinumab 875356-43-7
Fmoc-GGFG-Dxd Fmoc-GGFG-Dxd 1599440-11-5 C57H55FN8O12
Gadobutrol Gadobutrol 138071-82-6 C18H31N4O9.Gd
MK-677 MK-677 159634-47-6 C27H36N4O5S
2''-(5-ETHYL-3,4-DIPHENYL-PYRAZOL-1-YL)-BIPHENYL-3-YLOXY]ACETIC ACID 2''-(5-ETHYL-3,4-DIPHENYL-PYRAZOL-1-YL)-BIPHENYL-3-YLOXY]ACETIC ACID 300657-03-8 C31H26N2O3
N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl 1219976-29-0 C10H17ClN4O2
Clascoterone Clascoterone 19608-29-8 C24H34O5
XL518 XL518 934660-93-2 C21H21F3IN3O2
Tucatinib Tucatinib 937263-43-9 C26H24N8O2
FMoc-Val-Cit-PAB-MMAE FMoc-Val-Cit-PAB-MMAE 1350456-56-2 C73H104N10O14
Ivosidenib Ivosidenib 1448347-49-6 C28H22ClF3N6O3
GNE-140 (racemate) GNE-140 (racemate) 1802977-61-2 C25H23ClN2O3S2
PF-06882961 PF-06882961 2230198-02-2 C31H30FN5O4
LOXO-292 LOXO-292 2152628-33-4 C29H31N7O3
Tetraacetylphytosphingosine Tetraacetylphytosphingosine 13018-48-9 C26H47NO7
DPO-1 DPO-1 43077-30-1 C22H29OP
Maytansinol Maytansinol 57103-68-1 C28H37ClN2O8
Pixantrone Dimaleate Pixantrone Dimaleate 144675-97-8 C21H23N5O6
Alisol C 23-acetate Alisol C 23-acetate 26575-93-9 C32H48O6
Crisaborole Crisaborole 906673-24-3 C14H10BNO3
AC 010220 (dihydrochloride) AC 010220 (dihydrochloride) 1132827-21-4 C29H33ClN6O4S
Omadacycline Omadacycline 389139-89-3 C29H40N4O7
Sarecycline Hydrochloride Sarecycline Hydrochloride 1035979-44-2 C24H30ClN3O8
Relugolix Relugolix 737789-87-6 C29H27F2N7O5S
CPI-444 CPI-444 1202402-40-1 C20H21N7O3
SR9009 SR9009 1379686-30-2 C20H24ClN3O4S
 PTP Inhibitor V, PHPS1 PTP Inhibitor V, PHPS1 314291-83-3 C21H15N5O6S
ERDAFITINIB ERDAFITINIB 1346242-81-6 C25H30N6O2
ODM-201 ODM-201 1297538-32-9 C19H19ClN6O2
Fezolinetant Fezolinetant 1629229-37-3 C16H15FN6OS
EC330 EC330 2016795-77-8 C30H32F2O2
GDC-0077 GDC-0077 2060571-02-8 C18H19F2N5O4
GNE140 GNE140 2003234-63-5 C25H23ClN2O3S2
Calcium 2-oxoglutarate Calcium 2-oxoglutarate 71686-01-6 C5H8CaO5
APREMILAST (PDE inhibitor) APREMILAST (PDE inhibitor)
RU.521 RU.521 2262452-06-0 C19H12Cl2N4O3
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.